The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The boston area anticoagulation trial for atrial fibrillation investigators

New England Journal of Medicine

Volumn 323, Issue 22, 1990, Pages 1505-1511

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; STROKE; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; FEMALE; HEMORRHAGE; HUMAN; MALE; MIDDLE AGE; PROTHROMBIN TIME; RISK; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; WARFARIN;

EID: 0025241137     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199011293232201     Document Type: Article

References (23)

1. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28:973–7.
2. Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977; 40:509–13.
3. Dunn M, Alexander J, De Silva R, Hildner F. Antithrombotic therapy in atrial fibrillation. Chest 1989; 95: Suppl: 1 18S–127S.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med 1987; 147:1561–4.
5. Petersen P, Godtfredsen J, Boysen G, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989; 1:175–9.
6. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Warfarin to prevent thromboembolism in chronic atrial fibrillation. Lancet 1989; 1: 670.
7. Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990; 322:863–8.
8. Weyman AE. Cross-sectional echocardiography. Philadelphia: Lea & Febiger, 1982.
9. Hirsch J, Poller L, Deykin D, Levine M, Dalen JE. Optimal therapeutic range for oral anticoagulants. Chest 1989; 95: Suppl: 5S–11S.
10. Kistler JP, Ropper AH, Martin JB. Cerebrovascular diseases. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison's principles of internal medicine. 11th ed. New York: McGraw-Hill, 1987:1930–60.
11. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1–39.
12. Dixon WJ, Brown MB, Engelman L, et al., eds. BMDP statistical software. Berkeley: University of California Press, 1985:555–94.
13. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34:187–220.
14. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Wadsworth, 1982:300–2.
15. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34:585–612.
16. Petersen P, Boysen G, Godtfredsen J. Warfarin therapy and stroke prevention in patients with non-valvular atrial fibrillation. Geriatr Med Today 1990; 9:19–24.
17. Hughes MD, Pocock SJ. Stopping rules and estimation problems in clinical trials. Stat Med 1988; 7:1231–42.
18. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316:450–5.
19. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986:202, 213–4.
20. Benjamin EJ, Levy D, D'Agostino RB, et al. Mitral annular calcification and the risk of stroke in a free-living elderly cohort. Circulation 1989; 80: Suppl II: II-403. abstract.
21. Schlesselman JJ. Case–control studies: design, conduct, analysis. New York: Oxford University Press, 1982.
22. Poller L, McKeman A, Thomson JM, Elstein M, Hirsch PJ, Jones JB. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. BMJ 1987; 295:1309–12.
23. Conway EM, Bauer KA, Barzegar S, Rosenberg RD. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 1987; 80:1535–44.